Immunotherapy with an HIV-DNA Vaccine in Children and Adults
Therapeutic HIV immunization is intended to induce new HIV-specific cellular immune responses and to reduce viral load, possibly permitting extended periods without antiretroviral drugs. A multigene, multi-subtype A, B, C HIV-DNA vaccine (HIVIS) has been used in clinical trials in both children and...
Main Authors: | Paolo Palma, Lindvi Gudmundsdotter, Andrea Finocchi, Lars E. Eriksson, Nadia Mora, Veronica Santilli, Angela Aquilani, Emma C. Manno, Paola Zangari, Maria Luisa Romiti, Carla Montesano, Alba Grifoni, Andreas Brave, Karl Ljungberg, Pontus Blomberg, Stefania Bernardi, Eric Sandström, Bo Hejdeman, Paolo Rossi, Britta Wahren |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-07-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/2/3/563 |
Similar Items
-
Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment.
by: Anna-Karin Roos, et al.
Published: (2009-01-01) -
Therapeutic DNA vaccination of vertically HIV-infected children: report of the first pediatric randomised trial (PEDVAC).
by: Paolo Palma, et al.
Published: (2013-01-01) -
Do circulating HIV vaccine plasmids contribute to immunogenicity in humans?
by: Albert J, et al.
Published: (2006-12-01) -
Potent cellular and humoral immunity against HIV-1 elicited in mice by a DNA-prime/MVA-boost vaccine regimen intended for human use
by: Biberfeldt Gunnel, et al.
Published: (2006-12-01) -
Immunization of mice with the <it>nef </it>gene from Human Immunodeficiency Virus type 1: Study of immunological memory and long-term toxicology
by: Engström Gunnel, et al.
Published: (2007-07-01)